Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43063-482

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43063-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

Chemical structure of lisinopril dihydrate, illustrating its molecular arrangement including functional groups and water of hydration.*

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

Chemical structure of hydrochlorothiazide, an active ingredient in Lisinopril and Hydrochlorothiazide tablets by PD-Rx Pharmaceuticals, Inc.*

FDA Label Image

Image (43063482)

Label for Lisinopril and Hydrochlorothiazide tablets 10 mg/12.5 mg, containing 30 tablets. The label features the NDC 43063-482-30 and is marked with PD-Rx Pharmaceuticals, Inc. as the labeler in Oklahoma City, OK. The label includes dosage instructions to take a specified number of tablets daily and warnings about keeping the medication out of reach of children and discontinuation upon pregnancy detection. Additional details include lot number G20C24 and expiration date 07/2022.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.